Association between microRNA polymorphisms and the risk of inflammatory bowel disease

Min Zhu1, Diangeng Li2, Meiling Jin2

  • 1Department of Oncology, Division of South Building, Chinese PLA General Hospital, Beijing 100853, P.R. China.

Insights

Single nucleotide polymorphisms (SNPs) in microRNAs (miRNAs) are linked to inflammatory bowel disease (IBD) and IBD-associated colorectal cancer (IBD-CRC). Specific SNPs in mir-146a and mir-149 influence IBD risk by altering miRNA expression, while a mir-196a SNP impacts IBD-CRC progression.

Area of Science:

  • Genetics
  • Molecular Biology
  • Gastroenterology

Background:

  • Single nucleotide polymorphisms (SNPs) in microRNA (miRNA) genes can affect miRNA expression and function.
  • These genetic variations may influence susceptibility to complex diseases like inflammatory bowel disease (IBD) and associated cancers.
  • Investigating specific miRNA SNPs offers insights into disease pathogenesis.

Purpose of the Study:

  • To evaluate the association between common SNPs in precursor miRNAs and the risk of IBD.
  • To assess the role of these SNPs in the development of IBD-associated colorectal cancer (IBD-CRC).
  • To examine the impact of these SNPs on miRNA expression levels.

Main Methods:

  • A hospital-based case-control study involving 468 IBD patients and 450 healthy controls from a Chinese population.
  • Genotyping of four common pro-miRNA SNPs using polymerase chain reaction (PCR)-restriction fragment length polymorphism.
  • Quantification of miRNA expression levels via reverse transcription-PCR.

Main Results:

  • The rs2910164 (mir-146a) SNP was associated with increased IBD risk (GC/CC genotypes) and lower mir-146a expression.
  • The rs2292832 (mir-149) SNP showed increased IBD risk (TT genotype, T allele) with reduced mir-149 expression.
  • The rs11614913 (mir-196a) SNP was linked to a higher risk of IBD-CRC (CC genotype).

Conclusions:

  • The mir-146a rs2910164 and mir-149 rs2292832 SNPs may contribute to IBD risk through altered miRNA expression.
  • The mir-196a rs11614913 SNP might play a role in the progression of IBD-associated colorectal cancer.
  • These findings highlight the clinical significance of miRNA genetic variations in IBD and IBD-CRC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
106